More Information
Summary:Disclosed are 1-hydroxy-1,3-dihydro-benzo[c][1,2]oxaboroles and their derivatives as represented by the general formula (I), wherein: R* is H; R3 is selected from H, cyano, substituted or unsubstituted nitroalkyl and substituted or unsubstituted aminoalkyl; Ra is YR5; wherein Y is O or S; R5 is selected from H, substituted or unsubstituted alkyl and substituted or unsubstituted heteroalkyl; and with the proviso that when R3 is H, Ra is not unsubstituted benzyloxy, Ra is not -OCH2COOH, Ra is not -OCH3 or Ra is not -OCH2CH3; or a salt, hydrate or solvate or anhydride thereof. Of particular importance is the compound (S)-1-hydroxy-3-aminomethyl-7-(3-hydroxypropyloxy)-3H-benzo[c][1,2]oxaborole. Further disclosed is a pharmaceutical formulation which comprises: a compound as defined above, or a pharmaceutically acceptable salt, hydrate, solvate or anhydride thereof, and a pharmaceutically acceptable excipient; for killing or preventing the growth of a microorganism, or for treating a bacterial infection in a mammal.
Bibliography:Application Number: NZ20080582706